UniProt ID | LAMC2_HUMAN | |
---|---|---|
UniProt AC | Q13753 | |
Protein Name | Laminin subunit gamma-2 | |
Gene Name | LAMC2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1193 | |
Subcellular Localization | Secreted, extracellular space, extracellular matrix, basement membrane. Major component. | |
Protein Description | Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Ladsin exerts cell-scattering activity toward a wide variety of cells, including epithelial, endothelial, and fibroblastic cells.. | |
Protein Sequence | MPALWLGCCLCFSLLLPAARATSRREVCDCNGKSRQCIFDRELHRQTGNGFRCLNCNDNTDGIHCEKCKNGFYRHRERDRCLPCNCNSKGSLSARCDNSGRCSCKPGVTGARCDRCLPGFHMLTDAGCTQDQRLLDSKCDCDPAGIAGPCDAGRCVCKPAVTGERCDRCRSGYYNLDGGNPEGCTQCFCYGHSASCRSSAEYSVHKITSTFHQDVDGWKAVQRNGSPAKLQWSQRHQDVFSSAQRLDPVYFVAPAKFLGNQQVSYGQSLSFDYRVDRGGRHPSAHDVILEGAGLRITAPLMPLGKTLPCGLTKTYTFRLNEHPSNNWSPQLSYFEYRRLLRNLTALRIRATYGEYSTGYIDNVTLISARPVSGAPAPWVEQCICPVGYKGQFCQDCASGYKRDSARLGPFGTCIPCNCQGGGACDPDTGDCYSGDENPDIECADCPIGFYNDPHDPRSCKPCPCHNGFSCSVMPETEEVVCNNCPPGVTGARCELCADGYFGDPFGEHGPVRPCQPCQCNNNVDPSASGNCDRLTGRCLKCIHNTAGIYCDQCKAGYFGDPLAPNPADKCRACNCNPMGSEPVGCRSDGTCVCKPGFGGPNCEHGAFSCPACYNQVKIQMDQFMQQLQRMEALISKAQGGDGVVPDTELEGRMQQAEQALQDILRDAQISEGASRSLGLQLAKVRSQENSYQSRLDDLKMTVERVRALGSQYQNRVRDTHRLITQMQLSLAESEASLGNTNIPASDHYVGPNGFKSLAQEATRLAESHVESASNMEQLTRETEDYSKQALSLVRKALHEGVGSGSGSPDGAVVQGLVEKLEKTKSLAQQLTREATQAEIEADRSYQHSLRLLDSVSRLQGVSDQSFQVEEAKRIKQKADSLSSLVTRHMDEFKRTQKNLGNWKEEAQQLLQNGKSGREKSDQLLSRANLAKSRAQEALSMGNATFYEVESILKNLREFDLQVDNRKAEAEEAMKRLSYISQKVSDASDKTQQAERALGSAAADAQRAKNGAGEALEISSEIEQEIGSLNLEANVTADGALAMEKGLASLKSEMREVEGELERKELEFDTNMDAVQMVITEAQKVDTRAKNAGVTIQDTLNTLDGLLHLMDQPLSVDEEGLVLLEQKLSRAKTQINSQLRPMMSELEERARQQRGHLHLLETSIDGILADVKNLENIRDNLPPGCYNTQALEQQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
250 | Phosphorylation | AQRLDPVYFVAPAKF HCCCCCEEEEEEHHH | 9.57 | 22817900 | |
265 | Phosphorylation | LGNQQVSYGQSLSFD HCCCCCCCCCCCEEE | 21.96 | 22817900 | |
273 | Phosphorylation | GQSLSFDYRVDRGGR CCCCEEEEEECCCCC | 15.55 | 22817900 | |
297 | Phosphorylation | EGAGLRITAPLMPLG CCCCCEEECCEECCC | 18.78 | 29083192 | |
342 | N-linked_Glycosylation | EYRRLLRNLTALRIR HHHHHHHHHHHHHHH | 41.53 | UniProtKB CARBOHYD | |
344 | Phosphorylation | RRLLRNLTALRIRAT HHHHHHHHHHHHHHH | 27.48 | 24719451 | |
362 | N-linked_Glycosylation | YSTGYIDNVTLISAR CCCCEEECEEEEEEE | 21.08 | UniProtKB CARBOHYD | |
578 | Sulfoxidation | RACNCNPMGSEPVGC CCCCCCCCCCCCCCC | 6.00 | 28465586 | |
636 (in isoform 2) | Ubiquitination | - | 37.42 | 21906983 | |
636 (in isoform 1) | Ubiquitination | - | 37.42 | 21906983 | |
636 | Ubiquitination | RMEALISKAQGGDGV HHHHHHHHHHCCCCC | 37.42 | 22817900 | |
686 | Phosphorylation | LQLAKVRSQENSYQS HHHHHHHHCCCCHHH | 44.85 | 23898821 | |
690 | Phosphorylation | KVRSQENSYQSRLDD HHHHCCCCHHHHHHH | 24.64 | 23898821 | |
762 | O-linked_Glycosylation | KSLAQEATRLAESHV HHHHHHHHHHHHHHH | 26.01 | 55831393 | |
762 | Phosphorylation | KSLAQEATRLAESHV HHHHHHHHHHHHHHH | 26.01 | - | |
767 | Phosphorylation | EATRLAESHVESASN HHHHHHHHHHHHHHC | 27.50 | - | |
771 | Phosphorylation | LAESHVESASNMEQL HHHHHHHHHHCHHHH | 35.59 | - | |
773 | Phosphorylation | ESHVESASNMEQLTR HHHHHHHHCHHHHHH | 46.09 | - | |
779 | Phosphorylation | ASNMEQLTRETEDYS HHCHHHHHHHCHHHH | 26.59 | - | |
787 | Acetylation | RETEDYSKQALSLVR HHCHHHHHHHHHHHH | 33.10 | 7974711 | |
791 | Phosphorylation | DYSKQALSLVRKALH HHHHHHHHHHHHHHH | 28.03 | 24719451 | |
803 | Phosphorylation | ALHEGVGSGSGSPDG HHHCCCCCCCCCCCH | 27.64 | 26091039 | |
805 | Phosphorylation | HEGVGSGSGSPDGAV HCCCCCCCCCCCHHH | 37.48 | 26091039 | |
807 | Phosphorylation | GVGSGSGSPDGAVVQ CCCCCCCCCCHHHHH | 22.86 | 26091039 | |
819 | Malonylation | VVQGLVEKLEKTKSL HHHHHHHHHHHHHHH | 55.24 | 26320211 | |
819 | Acetylation | VVQGLVEKLEKTKSL HHHHHHHHHHHHHHH | 55.24 | 178226349 | |
831 | O-linked_Glycosylation | KSLAQQLTREATQAE HHHHHHHHHHHHHHH | 23.33 | 73397645 | |
886 | O-linked_Glycosylation | DSLSSLVTRHMDEFK HHHHHHHHHCHHHHH | 21.83 | 55825213 | |
925 | Phosphorylation | EKSDQLLSRANLAKS HHHHHHHHHHHHHHH | 37.63 | 29888752 | |
932 | Phosphorylation | SRANLAKSRAQEALS HHHHHHHHHHHHHHH | 27.52 | 28102081 | |
942 | N-linked_Glycosylation | QEALSMGNATFYEVE HHHHHCCCCCHHHHH | 27.45 | UniProtKB CARBOHYD | |
950 | Phosphorylation | ATFYEVESILKNLRE CCHHHHHHHHHHHHH | 38.09 | 24719451 | |
977 | Phosphorylation | EEAMKRLSYISQKVS HHHHHHHHHHHHHHC | 25.18 | 22817900 | |
987 | Phosphorylation | SQKVSDASDKTQQAE HHHHCCCCHHHHHHH | 44.63 | 22817900 | |
999 | Phosphorylation | QAERALGSAAADAQR HHHHHHHHHHHHHHH | 18.65 | 28355574 | |
1033 | N-linked_Glycosylation | GSLNLEANVTADGAL CCCCEEEEEEHHHHH | 23.46 | UniProtKB CARBOHYD |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LAMC2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LAMC2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LAMC2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SLAP2_HUMAN | SLA2 | physical | 17353186 | |
TYY1_HUMAN | YY1 | physical | 16624538 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
226700 | Epidermolysis bullosa, junctional, Herlitz type (H-JEB) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-250; TYR-265 ANDTYR-273, AND MASS SPECTROMETRY. |